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ABSTRACT 
 
Asukamycin,  a  member  of  the  manumycin  family  of  antibiotics,  exhibits  strong  anti-
bacterial, antifungal, and anti-neoplastic activities. However, its production in the wild-
type strain of Streptomyces nodosus subsp. asukaensis ATCC 29757 is relatively low. 
Recently, the biosynthetic gene cluster for asukamycin was identified in the producing 
organism  and  among  the  36  genes reported  in  the  cluster,  six  (asuR1-asuR6)  were 
proposed to encode proteins that function as transcriptional regulators. To investigate 
their  involvement  in  asukamycin  biosynthesis  and  to  engineer  mutant  strains  of  S. 
nodosus that are able to produce large amounts of asukamycin, we carried out in vivo 
gene inactivation, transcriptional analysis of the biosynthetic genes in the mutants, and 
gene duplication in the producing strain of S. nodosus. The results show that two of the 
putative regulatory genes (asuR1 and asuR5) are critical for asukamycin biosynthesis, 
whereas  others  regulate  the  pathway  at  various  levels.  Overexpression  of  a  gene 
cassette harboring asuR1, asuR2, asuR3, and asuR4 in S. nodosus resulted in changes 
in  morphology  of  the  producing  strain  and  an  approximately  14-fold  increase  of 
asukamycin production. However, overexpression of the individual genes did not give a 
comparable cumulative level of asukamycin production, suggesting that some, if not all, 
of the gene products act synergistically to regulate the biosynthesis of this antibiotic. 
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INTRODUCTION 
 
The actinomycetes, especially those of the genus Streptomyces, have been known to 
be  a  prolific  source  of  bioactive  natural  products.  More  than  one-half  of  known 
antibiotics discovered during the past half century are of Streptomyces origin (Berdy 
2005).  However,  very  often  efforts  to  develop  these  antibiotics  for  clinical  uses  are 
hampered  by  the  low  availability  of  the  compounds,  mainly  due  to  their  suboptimal 
production under laboratory conditions. Therefore, strain and culture improvements are 
often necessary to achieve production suitable for further studies and clinical uses.  
 
Among potential antibiotics with interesting biological activities are the asukamycins, 
members of the manumycin family  of antibiotics produced by Streptomyces nodosus 
subsp.  asukaensis  ATCC  29757  (Figure  1).  They  have  pronounced  antibacterial, 
antifungal, and antineoplastic activities (Omura et al. 1976, Hu and Floss 2004, Shipley 
et  al.  2009),  but  their  production  by  S.  nodosus  ATCC  29757  under  known  culture 
conditions is relatively low (Omura et al. 1976, Hu and Floss 2004). Our initial attempts 
to improve asukamycin production by ribosome engineering (Wang et al. 2008) and pH 
shock  (Kim  et  al.  2007)  methodologies  gave  little  success  (data  not  shown).  More 
recently,  Rui  et  al.  reported  the  biosynthetic  gene  cluster  of  asukamycin  from  S. 
nodosus ATCC 29757 (Rui et al. 2010). Annotation of the cluster resulted in a total of 36 
orfs (Figure 2a), of which six (asuR1-asuR6) were proposed to encode proteins that 
function as transcriptional regulators. The asuR1-4 genes are clustered in an operon 
located  upstream  (on  the  left  arm)  of  the  cluster,  whereas  asuR5  and  asu6  are  in 
separate  operons  located  downstream  of  the  cluster  (on  the  right  arm)  (Figure  2a).   4 
Some of these proteins may be critical for the regulation of asukamycin production or 
acting  as  response  mechanisms  to  a  variety  of  environmental  signals  or  nutritional 
conditions. Proper manipulations of the expression of these proteins may enhance the 
production level of this important antibiotic. 
 
The  genes  asuR1  and  asuR6  encode  LuxR  family  regulators  with  a  conserved 
LuxR_C DNA binding domain in their C terminal region (Table 1). This domain contains 
a helix-turn-helix motif and is responsible for DNA binding. Proteins belonging to this 
group are mostly response regulators, some act as transcriptional activators, others as 
transcriptional repressors (Sitnikov et al. 1995, Baikalov et al. 1996). The gene asuR2 
encodes a protein similar to TetR family of transcriptional regulators, which are widely 
distributed  among  bacteria  with  an  HTH  DNA-binding  motif.  Members  of  this  family 
commonly negatively regulate antibiotic biosynthesis, efflux pumps, osmotic stress, and 
others (Ramos et al. 2005). The gene asuR3 encodes an integral membrane protein 
with no meaningful similarity to known regulators. On the other hand, asuR4 and asuR5 
encode a cold-shock protein and a SARP family protein, respectively. Whereas cold 
shock  proteins  more  likely  function  as  response  mechanisms  to  temperature-related 
environmental conditions (Horn et al. 2007), members of the SARP family are normally 
involved in the regulation of secondary metabolite biosynthesis (Wietzorrek and Bibb 
1997, Sheldon et al. 2002). To investigate the putative involvement of these regulatory 
genes  in  asukamycin  biosynthesis  we  carried  out  in  vivo  gene  inactivation  and 
determined by RT-PCR their implications on the transcription of a select set of structural 
genes and their effects on the production level of asukamycin in S. nodosus. We also   5 
cloned and introduced the regulatory genes, either in combination or individually, into 
the asukamycin producer and analyzed their effects on asukamycin production. In this 
paper, we report our findings on the role of these putative regulatory genes and their 
implications  in  the  phenotypic  changes  of  the  bacteria  and  the  production  of 
asukamycin. 
 
MATERIALS AND METHODS 
Strains, plasmids and general methods 
The strains used in this study are listed in Table S1.  The general techniques for PCR 
and  cloning  followed  Sambrook  et  al.  (Sambrook  and  Russell  2001).  Genetic 
manipulations of Streptomyces followed Kieser et al. (Kieser et al. 2000). For spore 
production, S. nodosus strains were cultured on YM agar medium (yeast extract 0.3%, 
malt  extract  0.3%,  peptone  0.5%,  dextrose  1%,  agar  2%)  for  4  days  at  30  °C.  Taq 
polymerase, high-fidelity Taq polymerase, T4 DNA ligase, restriction enzymes and other 
related enzymes were purchased from Invitrogen. 
 
Construction of mutant strains of S. nodosus 
For gene deletion of asuR1, asuR2, asuR3, asuR4, asuR5 and asuR6 in S. nodosus, 
plasmids pTMPX57, pTMPX67, pTMYS008, pTMPX68, pTMPX58 and pTMPX30 were 
constructed (Table S1). To construct ∆asuR1, ∆asuR2, ∆asuR3, ∆asuR4 and ∆asuR5 
mutants,  the  in-frame  deletion  strategy  was  employed  to  decrease  the  possibility  of 
polar effects. For ∆asuR1, 2-kb downstream and upstream DNA fragments of asuR1 
were amplified by PCR with the primer pairs asuR1_left and asuR1_right (Table S2),   6 
which  were  cloned  into  the  HindIII/KpnI  and  XbaI/HindIII  sites  of  the  cloning  vector 
pBluescript II SK (-), respectively. After confirmation by DNA sequencing, the upstream 
DNA  fragment  was  inserted  into  the  XbaI  and  HindIII  sites  of  the  plasmid  vector 
pJTU1278 (He et al. 2010) followed by the second insertion of the downstream DNA 
fragment  into  the  HindIII  and  KpnI  sites.  The  resulting  plasmid  pTMPX57  was 
introduced into S. nodosus by the standard E. coli-Streptomyces conjugation procedure 
(Kieser  et  al.  2000),  and  exconjugants  were  subsequently  selected  using  20  g/mL 
thiostrepton. Six colonies resistant to thiostrepton were picked and re-streaked onto YM 
medium  without  antibiotics  for  a  second  round  of  recombination.  Double  crossover 
mutants were screened by replica from the colonies grown on the YM medium. Mutants 
that lost resistance to thiostrepton were selected for further screening and genotypic 
confirmation by PCR. The same procedure was applied to the construction of ∆asuR2, 
∆asuR4 and ∆asuR5 mutants by their specific primer pairs for PCR amplification (Table 
S2).  
For ∆asuR3, 2-kb of the downstream and the upstream DNA fragments of asuR3 
were amplified by PCR with the primer pairs asuR3_left and asuR3_right (Table S2). 
The downstream DNA fragment was cloned into the HindIII and XbaI sites of the cloning 
vector  pIJ2925  (Janssen  and  Bibb  1993),  followed  by  the  second  insertion  of  the 
upstream  DNA  fragment  into  the  XbaI/NdeI  sites.  After  confirmation  by  DNA 
sequencing, the plasmid was first digested with NdeI and the protruding ends were filled 
with  Large  (Klenow)  Fragment  (Promega).  The  Klenow-treated  plasmid  was  then 
digested with HindIII and the downstream/upstream fragment was inserted into the XbaI 
(blunt-ended with Klenow fragment) and HindIII sites of the plasmid vector pTMN002   7 
(Ito  et  al.  2009). The  same  transformation procedure  was  followed  to  introduce  this 
plasmid  into  S.  nodosus.  Four  colonies  resistant  to  apramycin  were  picked  and  re-
streaked  onto  YM  medium  without  antibiotics  for  a  second  round  of  recombination. 
Double crossover mutants were screened by replica from the colonies grown on the YM 
medium. Mutants that lost resistance to apramycin were selected for further screening 
and genotypic confirmation by PCR.  
The construction strategy for the ∆asuR6 mutant was modified slightly due to the 
difficulties of getting mutants by in-frame deletion. After cloning of the 2-kb downstream 
and upstream DNA fragments into the EcoRI/HindIII and XbaI/EcoRI sites of pJTU1278, 
an additional ~1-kb gene cassette for apramycin resistance was further inserted into the 
EcoRI site of the vector to give pTMPX30. The same transformation procedure was 
followed  to  introduce  this  plasmid  into  S.  nodosus.  Around  50  colonies  resistant  to 
apramycin were inoculated onto two types of YM medium plates with only apramycin or 
both  thiostrepton  and  apramycin  for  double  crossover  mutants  screening.  Colonies 
resistant to apramycin but sensitive to thiostrepton were picked and subjected to further 
PCR confirmation. 
 
Fermentation, HPLC, and LC-MS analysis of the metabolites 
S. nodosus wild-type and mutant strains were grown on solid YM medium (2% agar) for 
spore production, and harvested. For asukamycin production, strains were inoculated in 
30-mL seed  medium for 2 days followed by a 3-day cultivation in 50 mL production 
medium (Hu and Floss 2004). Each strain was cultured in triplicate. The fermentation 
broth was collected after 5000-rpm centrifugation for 15 min, and extracted twice with   8 
equal volumes of EtOAc. After evaporation, the EtOAc extracts were dissolved in 10 mL 
MeOH and subjected to HPLC or LC-MS analysis. All fermentation experiments  and 
analyses were performed twice to confirm consistency. 
 
HPLC was performed as follows: A reversed-phase octadecyl silica column (YMC-pack 
ODS-A 250 x 4.6 mm, YMC) was equilibrated with 50% solvent B (acetonitrile, 0.1% 
formic acid) and 50% solvent A (water, 0.1% formic acid) for 15 min, then developed 
with a gradient of 50-100% solvent B in solvent A for 30 min, and washed with 100% 
solvent B for 10 min. The flow rate was 0.4 mL/min and 10 µL of crude extract was 
injected each time. The compounds were monitored at 315 nm. For LC-MS analysis, a 
negative  ion  mode  electrospray  mass  spectrometry  was  used.  For  quantification  of 
asukamycin in the wild-type and the mutant samples, areas under the curves of HPLC 
peaks  were  directly  compared  with  those  of  a  standard  asukamycin  sample  (0.1 
mg/mL), and the yields of asukamycin produced by the wild-type and the mutant strains 
were calculated accordingly. 
 
RNA isolation and reversed-transcription PCR (RT-PCR) 
Wild-type and mutant strains of S. nodosus were inoculated into production medium and 
cells were harvested for RNA extraction after 1-3 days incubation. RNAs were extracted 
from  the  cells  using  Trizol  (Invitogen)  after  a  30  min  treatment  of  the  cells  with 
lysozyme. RNAs were precipitated by an equal volume of isopropanol and washed with 
70% ethanol. The RNA samples were then treated with DNase (RNase-free, Invitrogen) 
to  remove  residual  genomic  DNA  and,  after  quantification,  reverse-transcribed  into   9 
cDNA  using  “RevertAid  First  Strand  cDNA  Synthesis”  kit  (MBI  Fermentas).  The 
products (20 ng) were then subjected to PCR amplification (25 cycles). Primers P1 – P8 
(Table  S1)  were  used  to  determine  the  transcription  levels  of  genes  from  the 
asukamycin pathway, and primers for hrdB gene were used as an internal control. PCR 
conditions were: template DNA denatured at 94 °C for 5 min, then 94 °C 30 sec, 60 °C 
30 sec, 72 °C 30 sec, for 25 cycles. 
 
Overexpression of regulatory genes in S. nodosus 
Plasmid  pTMW50,  an  integrative  vector  that  harbors  the  constitutive  expression 
promoter ermE (Figure 5a), was used as the overexpression vector for the regulatory 
gene(s)  in  S.  nodosus.  The  3-kb  PCR  product  of  regulatory  genes  asuR1-4  was 
amplified from genomic DNA by PCR with primers described in Table S2 and cloned into 
the XbaI and BamHI sites of pBluescript II SK(-) for DNA sequencing. After confirmation, 
this  fragment  was  inserted  immediately  downstream  of  the  ermE  promoter  at  the 
corresponding sites of pTMW50 and the resulting plasmid pTMPX75 was introduced 
into  S.  nodosus  by  conjugation.  Colonies  resistant  to  apramycin  were  selected  and 
confirmed by PCR using primers specific to acc(3)IV gene. For the co-overexpression of 
asuR5 and asuM1, a 2.8-kb fragment containing these two genes was amplified from 
genomic  DNA  and  cloned  into  XbaI  and  BamHI  sites  of  pBluescript  II  SK(-).  The 
fragment  was  subcloned  into  pTMW50  and  the  resulting  plasmid  pTMPX76  was 
introduced  into  S.  nodosus  by  conjugation  following  the  same  procedure  described 
above.   10 
For the overexpression of a single regulatory gene in S. nodosus, asuR1, asuR2, 
asuR3 and asuR4 were cloned individually into the XbaI and BamHI sites of pBluescript 
II  SK(-),  and  after  DNA  sequencing  confirmation  the  genes  were  subcloned  into 
pTMW50 and overexpressed in S. nodosus following the same procedures described 
above. The yields of asukamycin production in the transformants  were quantified by 
HPLC. 
 
Bioactivity assay  
Antibacterial activity of  metabolites isolated from  the  mutants  was  determined  by an 
agar diffusion assay. The test strain Staphylococcus aureus was streaked on N medium 
(0.5% peptone, 0.5% meat extract, 1.2% agar) and grown at 37 °C overnight. A single 
colony was inoculated into N liquid medium and incubated in a shaker (200 rpm) at 
37°C overnight. The cell suspension (1 mL) was mixed thoroughly with warm N medium 
(100 mL) and poured onto Petri Dishes (100*15 mm, VWR). A methanolic solution of 
each sample (15 L) was loaded onto a sterile blank paper disk (Becton-Dickinson) and 
allowed to dry in the sterile hood for 30 min. The sample-loaded paper disks were then 
placed onto the solidified agar plates and incubated at 37 °C for 12 h. When needed, 
1%  MTT  (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide)  (1  mL)  was 
added onto the plates to better visualize the inhibition zone. 
 
RESULTS   11 
Genetic  Analysis  of  the  Putative  Regulatory  Genes  in  the  Asukamycin 
Biosynthetic Gene Cluster 
Recent studies on the biosynthetic gene cluster of asukamycin and careful inspection of 
the bioinformatics data revealed that at least six putative regulatory genes are located 
within  the  cluster.  To  determine  the  involvement  of  these  putative  regulatory  genes 
(asuR1,  asuR2,  asuR3,  asuR4,  asuR5  and  asuR6)  in  asukamycin  biosynthesis,  we 
inactivated the genes individually by in-frame gene deletion (for asuR1, -R2, -R3, -R4, -
R5) or gene replacement with aac(3)IV (for asuR6). The mutants were confirmed by 
PCR (Figures 2b and 3a).  
Cultivation of the six resulting mutant and the wild-type strains of S. nodosus was 
carried out in triplicate and the yields of asukamycin were quantified and compared by 
HPLC analysis. As shown in Figure 3b, mutant strains lacking asuR1 or asuR5 were no 
longer able to produce asukamycin, suggesting that AsuR1 and AsuR5 are essential 
regulators, most likely involved in the transcriptional initiation of structural genes, or act 
as switches specific for asukamycin production. On the other hand, ∆asuR2, ∆asuR4 
and ∆asuR6 mutants still produced asukamycin, but at reduced levels (5%, 13% and 
33%  of  that  of  the  wild-type,  respectively),  suggesting  that  the  corresponding  three 
proteins also play a role in regulating asukamycin biosynthesis, albeit less significantly 
than  AsuR1  and  AsuR5.  Finally,  no  significant  differences  in  asukamycin  production 
were  observed  in  ∆asuR3  mutant  compared  to  the  wild-type,  suggesting  that  this 
unknown integral membrane protein is not directly involved in asukamycin biosynthesis. 
 
Transcriptional Analysis of Asukamycin Biosynthetic Genes in the Mutants   12 
The  decreased  production  level  of  asukamycin  in  the  mutants  indicates  possible 
positive regulatory roles of AsuR1, -R2, -R4, -R5, and -R6 in the pathway. To determine 
the range of the transcriptional regulation of these proteins RT-PCR was employed to 
establish the transcription levels of various asu structural genes. Eight pairs of primers 
(1-8) representing eight operons that cover the majority of the asukamycin biosynthetic 
cluster (Figure 4a), and one primer pair for the hrdB gene (the internal control, (Kieser 
et al. 2000)) were used to generate cDNAs. The selected genes have been proposed to 
be involved in the formation of the core unit 3-amino-4-hydroxybenzoic acid (asuA2), 
the cyclohexane ring (asuB1), the polyketide chains (asuC3, asuC9, asuC12), and the 
2-amino-3-hydroxycyclopent-2-enone  moiety  (asuD2)  (Rui  et  al.  2010).  In  addition, 
genes that encode a tailoring enzyme (asuE1) and a putative export protein (asuM1) 
were also examined. The RNA templates were isolated from the mutants and the wild-
type  cells  from  1-day,  2-day,  and  3-day  cultivations  in  the  production  medium.  The 
results showed that compared to the wild-type strain most of the structural genes in 
∆asuR1 and ∆asuR5 were down-regulated during the 3-day period, suggesting wide-
ranging regulatory spectra for AsuR1 and AsuR5. The results are consistent with those 
of  the  metabolic  analyses, in  which  no  asukamycin  production  was  observed in  the 
∆asuR1 and ∆asuR5 mutants (Figure 3b). Decreased transcriptional levels of certain 
genes, e.g., asuE1, asuC9, asuA2, and asuC12, were also observed in the ∆asuR6 
mutant, particularly on Day 1 and Day 2, suggesting a narrower regulatory spectrum for 
AsuR6. However, the expression levels of the suppressed genes rebounded on Day 3, 
resulting in an overall 33% of asukamycin production in the mutant compared to the 
wild-type strain (Figure 3b).    13 
 
Surprisingly, the transcription levels for all genes analyzed in ∆asuR2 and ∆asuR4 
were comparable to or higher than those in the wild-type, but the overall production of 
asukamycin in those mutants was only 5% and 13% of the wild-type level, respectively. 
These results suggest that AsuR2 and AsuR4 do not directly regulate the transcription 
of the representative genes analyzed in this study, but may play a role in asukamycin 
biosynthesis by regulating other genes in the cluster or elsewhere in the genome. On 
the other hand, asuC9 was not expressed in all the strains tested at different cultivation 
time. This may be due to a number of factors, e.g., the gene is silent or its expression 
level is too low to be detected by the assay. Further investigations are necessary to 
decipher this complex regulatory network. 
 
Overexpression of asuR1-R4 and asuM1-R5 Cassettes in S. nodosus 
The  down-regulation  of  asukamycin  biosynthesis  in  the  ∆asuR1-asuR6  mutants 
underscores  the  importance  of  these  regulatory  genes.  Therefore,  we  carried  out 
overexpression experiments using two sets of genes (excluding asuR6, as its deletion 
from the chromosome has the smallest effect on asukamycin production) in S. nodosus. 
The  asu1-asu4  gene  locus,  located  upstream  of  the  asukamycin  biosynthetic  gene 
cluster,  was  cloned  into  the  integration  vector  pTMW50  (Figure  5a),  a  pSET152 
derivative  containing  the  aac3(IV)  gene  and  an  ermE  promoter,  to  give  pTMPX75 
(Figure  5b).  Similarly,  asuM1  and  asuR5,  located  downstream  of  the  cluster,  were 
cloned  into  pTMW50  to  give  pTMPX76.  The  asuM1  gene  was  included  because  it 
encodes  an  efflux  protein  similar  to  EmrB  and  is  located  within  the  same  operon   14 
adjacent to asuR5. The plasmids pTMPX75 and pTMPX76 were then introduced into S. 
nodosus  and  the  morphological phenotypes  of  the  transformants  and  the production 
level  of  asukamycin  were  determined.  Distinct  morphological  phenotypes  were 
observed in the pTMPX75 transformant after 3-day cultivation on the solid CM medium 
(Figures  6a  and  6b).  The  strain  displayed  sparse  aerial  mycelia  and reduced  spore 
production.  Interestingly,  it  also  produced  a  large  amount  of  visible  yellowish 
substance(s); this was later identified as asukamycin, which had diffused into the agar 
medium. Cultivation of the transformant in the production medium followed by HPLC 
analysis of the culture broth revealed a significant increase of asukamycin production in 
this strain (264 ± 28 mg/L), approximately 14-fold higher than that of the wild-type (19.1 
± 3.3 mg/L) (Figure 6c). On the other hand, the pTMPX76 transformant did not show 
any recognizable morphological differences from the wild-type (Figures 6a and 6b) nor 
did it show significant increases in asukamycin production (22 ± 3.8 mg/L) (Figure 6c). 
Further  confirmation  of  the  relative  production  levels  of  asukamycin  in  these 
transformants  was  performed  by  comparing  the  antibacterial  activity  of  the  extracts 
using an agar diffusion assay with Staphylococcus aureus as the indicator. The results 
showed  that  samples  from  the  pTMPX75  transformant  had  a  much  larger  growth 
inhibition zone than that of the wild-type (2.84 cm
2 vs 0.78 cm
2, Figure 6d), consistent 
with the estimated production levels of asukamycin in those strains. 
 
AsuR1, AsuR2, AsuR3, and AsuR4 Are Likely Pathway-Specific Regulators 
As overexpression of pTMPX75 in S. nodosus significantly improved the production of 
asukamycin,  we  attempted  to  express  the  gene  cassette  in  Streptomyces  pactum,   15 
another  antibiotic-producing  actinomycete,  which  produces  the  anticancer  antibiotics 
pactamycin, the piericidins, and many others (Bhuyan 1962, Matsumoto et al. 1987). 
The  S.  pactum  strain  was  transformed  with  pTMPX75  by  conjugation,  and  the 
transformant  was  cultured  and  production  of  antibiotics  analyzed.  However,  no 
significant  increase  of  pactamycin  and  piericidin  production  was  observed  (data  not 
shown), suggesting that these regulatory genes are likely pathway specific and do not 
function in S. pactum. 
 
Dissecting the Role of Individual asuR1, asuR2, asuR3, and asuR4 in S. nodosus 
The significant effect of asuR1-R4 cassette in asukamycin production prompted us to 
investigate the role of each of these genes in asukamycin production. The genes were 
individually cloned into the vector pTMW50 to generate plasmids pTMPX82, pTMPX83, 
pTMPX84,  and  pTMPX85  (Figure  5b).  The  plasmids  were  then  introduced  into  S. 
nodosus and the resulting transformants were investigated for asukamycin production. 
The  asuR3  gene,  which encodes  a  putative  membrane  protein,  was  included in  the 
study to explore the possibility of its involvement in asukamycin biosynthesis. HPLC 
analysis and agar diffusion assay were employed to determine the production levels of 
asukamycin  in  those  strains.  Interestingly,  the  results  showed  that  none  of  the 
transformants could produce asukamycin at the level of those harboring the asuR1-R4 
cassette (Figure 6c). Whereas the strain that contains pTMPX82 (asuR1) has a 3.5-fold 
increase  in  asukamycin  production  (70±13  mg/L),  other  single  gene  transformants, 
including empty pTMW50, surprisingly showed reduced asukamycin production relative 
to the wild-type (Figure 6c). While the reason for the reduced production is unclear, the   16 
result confirmed that AsuR1 is an important regulator in asukamycin biosynthesis, and 
may  work  synergistically  with  other  proteins.  Also,  it  is  more  likely  that  the  slight 
reduction in asukamycin production of the other transformants (13%, 58%, and 54% of 
that of the wild-type for asuR2, asuR3, and asuR4 overexpression, respectively) is due 
to some unknown factor related to the plasmid they carry, rather than the presence of 
the genes, as indicated by the similar reduction (11% of that of the wild-type) observed 
in the strain carrying only empty pTMW50 (Figure 6c). 
 
DISCUSSION  
In recent years, targeted manipulation of regulatory genes has become one of the major 
techniques to improve antibiotic production and has several advantages over laborious 
and time-consuming classical techniques. This molecular genetic approach becomes 
more applicable due to the improved knowledge of natural product biosynthesis and 
regulation, the more readily accessible genetic tools, and the relatively low costs of DNA 
sequencing  (Chen  et  al.  2010).  To  date,  numerous  regulatory  proteins  involved  in 
antibiotic production have been identified in Streptomyces. Pathway-specific regulators 
(e.g., ActII-ORF4, RedD, CdaR), many of which belong to the SARP-family proteins with 
a  typical  OmpR-like  conserved  domain  in  the  N-terminus,  specifically  regulate  the 
transcription of certain biosynthetic genes (Wietzorrek and Bibb 1997). On the other 
hand, pleiotropic regulators (e.g., two-component regulators, AfsR, AdpA) were found to 
have  a much  broader  regulatory  spectrum  than  pathway-specific  regulators,  as  they 
usually control more than one biosynthetic pathway by activating or repressing pathway-
specific regulators (Bibb 1996). In some cases, these regulators (for example, AdpA)   17 
are  also  found  to  be  associated  with  morphological  differentiation  or  other  cellular 
processes of Streptomyces (Lopez-Garcia et al. 2010).  
 
In  the  present  study,  we  have  confirmed  five  positive  regulators  of  asukamycin 
biosynthesis  and  discovered  that  each  of  them  regulates  the  pathway  by  different 
degrees.  Whereas  inactivation  experiments  and  transcriptional  analysis  by  RT-PCR 
revealed that AsuR1 (a LuxR family regulator) and AsuR5 (a SARP family regulator) are 
critical for asukamycin biosynthesis, results from overexpression experiments suggest 
that, as in many transcriptional regulatory systems, these regulators operate with other 
proteins in a more complex system. This conclusion was based on the fact that over-
expression  of  a  gene  cassette  containing  asuR1,  -R2,  -R3,  and  -R4  in  S.  nodosus 
increased the production of asukamycin approximately 14-fold over that of the wild-type, 
whereas over-expression of the individual genes only gave a modest increase or no 
increase at all. Great enhancements of antibiotic production were also observed when 
pTMPX75, which contains the asuR1-4 cassette, was incorporated into three other S. 
nodosus mutant strains that produce asukamycin congeners (data not shown). To our 
surprise, pTMPX76,  which  contains  asuR5 (a  member  of  the  SARP  family),  did  not 
significantly increase the production of asukamycin.  
 
In addition to the overproduction of asukamycin, abnormal growth with sparse aerial 
mycelia and loss of sporulation was also observed in the strain containing pTMPX75. 
This  observation  provided  one  more  example  of  close  relationships  between  the 
morphological differentiation and antibiotic production in Streptomyces (Xie et al. 2009,   18 
Lu  et  al.  2011).  It  is  believed  that  further  elevation  of  antibiotic  production  can  be 
achieved  through  proper  coordination  of  morphological  differentiation  and  secondary 
metabolism in Streptomyces, as well as the genetic manipulation of pathway specific 
regulatory  genes.  These  results  demonstrate  the  importance  of  targeted  genetic 
manipulation  as  a  powerful  approach  to  improve  antibiotic  production  in 
microorganisms.  
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FIGURE CAPTIONS 
Figure  1.  The  chemical  structure  of  asukamycin  and  manumycin.  Asukamycin 
differs from manumycin in the upper hydrocarbon chains highlighted with bold lines. 
 
Figure 2. Genetic disruption of the regulatory genes asuR1, asuR2, asuR3, asuR4, 
asuR5 and asuR6. a Genetic organization of the asukamycin gene cluster. b Illustration 
of  genetic disruption  strategy  and  the  sizes  of  PCR  products  before  and  after  gene 
disruption. 
 
Figure  3.  Construction  of  asuR1,  asuR2,  asuR3,  asuR4,  asuR5,  asuR6 
mutants and their asukamycin production. a PCR verification of the mutants. W, wild 
type; M, mutant. b Quantification of the asukamycin production in the mutant and wild 
type strains. 
 
Figure 4. Transcriptional analysis of asukamycin structural genes. a The primers 
used  in  the  RT-PCR  experiments  are  indicated  with  short  blue  lines  above  the 
representative  asukamycin  biosynthetic  genes,  primers  for  hrdB  gene  used  for  the   21 
internal  control  of  RT-PCR.    b  RT-PCR  analysis  of  the  transcription  of  asukamycin 
biosynthetic genes from the wild type and the mutants. Three time points from day 1 to 
day 3 were used for RNA sample preparation. 
 
Figure 5. Overexpression of regulatory genes in S. nodosus. a The map of plasmid 
vector  pTMW50  used  for  overexpression.  This  plasmid  contains  a  constitutively 
expressed promoter ermE. The restriction sites BamHI and XbaI were used for cloning. 
b  Illustration  of  the  plasmid  construction  strategy  used  in  the  overexpression  of 
regulatory genes.  
 
Figure 6. The phenotypes of wild-type S. nodosus and strains transformed with plasmid 
pTMW50, pTMPX75, pTMPX76, pTMPX82, pTMPX83, pTMPX84 and pTMPX85. a The 
front view of the plate: mutant and wild-type strains were cultivated on YM medium for 3 
days;  the  pTMPX75  transformant  displayed  sparse  aerial  mycelia,  reduced  spore 
production, and increased asukamycin production. b The back view of the plate. c The 
quantification of  asukamycin  production  from  the  above  strains  after  fermentation. d 
Antibacterial  assay  of  the  metabolites  isolated  from  the  above  strains.  1,  50  μg/mL 
asukamycin  standard;  2,  wild-type;  3,  pTMW50;  4,  pTMPX75;  5,  pTMPX76;  6, 
pTMPX82; 7, pTMPX83; 8, pTMPX84; 9, pTMPX85. 
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Table 1. The proposed biological functions and the conserved domains for the possible 
regulatory proteins encoded by asukamycin biosynthetic gene cluster 
LuxR_C_like: C-terminal DNA-binding domain of LuxR-like proteins (Sitnikov et al. 1995, Baikalov et al. 
1996). 
CSP_CDS: Cold-Shock Protein (CSP) contains an S1-like cold-shock domain (CSD) (Horn et al. 2007). 
Trans_reg_C: Transcriptional regulatory protein, C terminal (Wietzorrek and Bibb 1997, Sheldon et al. 
2002). 
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